Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |